Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196.
De Wit S, Bonnet F, Osiyemi O, Bisshop F, Olalla J, Routy JP, Wyen C, Moodley R, Pappa K, Wang R, Oyee J, Saggu P, Letang E, Wynne B, Jones B, Smith KY, Ait-Khaled M.
De Wit S, et al. Among authors: wynne b.
J Acquir Immune Defic Syndr. 2024 Mar 1. doi: 10.1097/QAI.0000000000003395. Online ahead of print.
J Acquir Immune Defic Syndr. 2024.
PMID: 38346427